Strattera Labeling Adds Bolded Warning For Severe Liver Injury

Lilly revises labeling following two cases of severe liver injury attributed to the attention deficit/hyperactivity disorder treatment. The company plans to issue a "Dear Health Care Professional" letter Jan. 3.